Patients report significant improvements in energy levels and a sense of wellbeing after receiving IV fluids
Its patented formula: Eases digestive discomfort such as occasional nausea, diarrhea, bloating, and constipation Neutralizes harmful pathogens in the gut Strengthens intestinal lining and stabilizes gut integrity Enhances nutrient absorption for optimal health Supports a balanced gut microbiome with prebiotic-rich ingredients When taken as directed, Relesium has been shown to significantly reduce the occasional adverse GI-related symptoms of GLP-1 medications, providing much-needed relief without compromising the efficacy of the drugs
PMID 38169018
These medicines include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight management), liraglutide (Saxenda for weight management, Victoza for diabetes), dulaglutide (Trulicity for diabetes), and tirzepatide (Mounjaro for diabetes), which combines GLP-1 with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism
Clinical trials have demonstrated significant reductions in hemoglobin A1c levels (approximately 1.52.0% from baseline) and substantial weight loss (averaging 1015% of body weight with higher doses)